Glycaemic Effects of a 156-km Ultra-trail Race in Athletes: An Observational Field Study.

Cassandra Parent, Pauline Baron, Virginie Gabel, Stéphane Besnard, Pierre-Louis Delaunay, Quentin Martinet, Jean-Charles Vauthier, Corentin Hingrand, Benoît Mauvieux, Romain Jouffroy, Rémi Rabasa-Lhoret, Philippe Noirez, Elsa Heyman, Patrice Maboudou, Elodie Lespagnol, Rémy Hurdiel, François-Xavier Gamelin, Joris Heyman

Journal: Sports medicine (Auckland, N.Z.) 2024;54(8):2169-2184

PMID: 38555307

Abstract

BACKGROUND

Ultra-trail running races pose appreciable physiological challenges, particularly for glucose metabolism. Previous studies that yielded divergent results only measured glycaemia at isolated times.

OBJECTIVES

We aimed to explore the impact of an ultra-endurance race on continuously measured glycaemia and to understand potential physiological mechanisms, as well as the consequences for performance and behavioural alertness.

METHODS

Fifty-five athletes (78% men, 43.7 ± 9.6 years) ran a 156-km ultra-trail race (six 26-km laps, total elevation 6000 m). Participants wore a masked continuous glucose monitoring sensor from the day before the race until 10 days post-race. Blood was taken at rest, during refuelling stops after each lap, and after 24-h recovery. Running intensity (% heart rate reserve), performance (lap times), psychological stress, and behavioural alertness were explored. Linear mixed models and logistic regressions were carried out.

RESULTS

No higher risk of hypo- or hyperglycaemia was observed during the exercise phases of the race (i.e. excluding stops for scientific measurements and refuelling) compared with resting values. Laps comprising a greater proportion of time spent at maximal aerobic intensity were nevertheless associated with more time > 180 mg/dL (P = 0.021). A major risk of hyperglycaemia appeared during the 48-h post-race period compared with pre-race (P < 0.05), with 31.9% of the participants spending time with values > 180 mg/dL during recovery versus 5.5% during resting. Changes in circulating insulin, cortisol, and free fatty acids followed profiles comparable with those usually observed during traditional aerobic exercise. However, creatine phosphokinase, and to a lesser extent lactate dehydrogenase, increased exponentially during the race (P < 0.001) and remained high at 24-h post-race (P < 0.001; respectively 43.6 and 1.8 times higher vs. resting). Glycaemic metrics did not influence physical performance or behavioural alertness.

CONCLUSION

Ultra-endurance athletes were exposed to hyperglycaemia during the 48-h post-race period, possibly linked to muscle damage and inflammation. Strategies to mitigate muscle damage or subsequent inflammation before or after ultra-trail races could limit recovery hyperglycaemia and hence its related adverse health consequences.

TRIAL REGISTRATION NUMBER

NCT05538442 2022-09-21 retrospectively registered.

© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Address: Univ. Lille, Univ. Artois, Univ. Littoral Côte d'Opale, ULR 7369 - URePSSS - Unité de Recherche Pluridisciplinaire Sport Santé Société, 59000, Lille, France.; Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada.; Department of Nutrition, Université de Montréal, Montréal, Québec, Canada.; UR 7480 Vertex - Université de Caen, Caen, France.; Univ. Lille, Univ. Artois, Univ. Littoral Côte d'Opale, ULR 7369 - URePSSS - Unité de Recherche Pluridisciplinaire Sport Santé Société, 59000, Lille, France.; Département de Médecine Générale, Faculté de Médecine - Département du Grand Est de Recherche en Soins Primaires, Université de Lorraine, Nancy, France.; Laboratoire Interpsy (UR 4432), Université de Lorraine, Nancy, France.; Institute for Research in bioMedicine and Epidemiology of Sport (IRMES), Paris, France.; T3S, INSERM UMR-S 1124, University of Paris Cité, Paris, France.; Département des Sciences de l'activité Physique, Université du Québec à Montréal, Montreal, Canada.; PSMS, University of Reims Champagne Ardenne, Reims, France.; PSMS, University of Reims Champagne Ardenne, Reims, France.; UR 7480 Vertex - Université de Caen, Caen, France.; CHU de Caen, Caen, France.; CNRS, UMR 6118, Transferts d'eau et de Matière dans les Milieux Hétérogènes Complexes - Géosciences, Université Rennes, Rennes, France.; Laboratoire de Biochimie et Biologie Moléculaire, CHU de Lille, Pôle de Biologie Pathologie Génétique, Lille, France.; Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada.; Department of Nutrition, Université de Montréal, Montréal, Québec, Canada.; Intensive Care Unit, Ambroise Paré Hospital, Assistance Publique - Hôpitaux de Paris, Boulogne Billancourt, France.; Centre de Recherche en Epidémiologie et Santé des Populations - U1018, INSERM - Paris Saclay University, Paris, France.; EA 7329 - Institut de Recherche Médicale et d'Épidémiologie du Sport - Institut National du Sport, de l'Expertise et de la Performance, Paris, France.; Univ. Lille, Univ. Artois, Univ. Littoral Côte d'Opale, ULR 7369 - URePSSS - Unité de Recherche Pluridisciplinaire Sport Santé Société, 59000, Lille, France. [email protected].; Institut Universitaire de France, Paris, France. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.